Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2013-06-05 Director's Dealing
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 242.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the change, and consideration received. This type of document is a formal notification of personal share transactions by a company director. It does not contain financial performance data, management discussion, or other report content. Therefore, it fits the definition of 'Director's Dealing' filings.
2013-06-05 English
Shareholder Report - May 2013 4 pages 1.4MB
Fund Information / Factsheet Classification · 85% confidence The document is a shareholder quarterly report from May 2013 for Nanosonics. It contains detailed updates on product development, sales growth, market expansion, endorsements from healthcare facilities, and intellectual property protection. The content is narrative and descriptive, focusing on business progress and market activities rather than formal financial statements or regulatory disclosures. There are no indications of formal financial results, audit opinions, management changes, or regulatory filings. The document is not a formal Annual Report, Interim Report, Earnings Release, or any regulatory filing. It is a periodic shareholder communication providing business updates and company news, which aligns with the characteristics of a Fund Information / Factsheet (FS) or a shareholder newsletter. Given the detailed business updates and shareholder focus, the best fit is Fund Information / Factsheet (FS).
2013-05-14 English
Investor Presentation 24 pages 1.2MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation about Nanosonics, focusing on their infection control technology, product features, market penetration, sales distribution, financial performance, and company history. It includes extensive financial data, market analysis, and strategic priorities. The content is structured as a presentation with slides, charts, and tables, aimed at investors or stakeholders. There is no indication that this is an official annual report, audit report, earnings release, or regulatory filing. Instead, it matches the characteristics of an Investor Presentation (IP), which typically includes detailed financials, strategy, market position, and growth outlook presented in a slide format. The length (15,000 characters) and detailed content support this classification with high confidence.
2013-05-05 English
Change in substantial holding 4 pages 94.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under the Corporations Act 2001, which is a Notice of change of interests of a substantial holder. It details changes in voting power and relevant interests of a substantial shareholder in the company Nanosonics Limited. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2013-05-05 English
Nanosonics signs Toshiba as a UK distributor 1 page
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 17 April 2013 from Nanosonics Limited, reporting the signing of a distribution agreement with Toshiba Medical Systems for the UK market. It discusses the strategic partnership and market potential but contains no financial statements, regulatory filings, or detailed financial data. The document is relatively short (3125 characters) and serves as a business update or press release rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is an announcement of a business development, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement or business update that does not fit other specific categories.
2013-04-16 English
Appendix 4C - quarterly 4 pages 178.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C QUARTERLY REPORT' and specifies the quarter ended 31 March 2013. It contains detailed financial data including consolidated statement of cash flows, cash flow related to operating, investing, and financing activities, payments to directors, financing facilities, reconciliation of cash, and compliance statement signed by the CEO. The presence of actual financial statements and substantive financial data for a quarter indicates this is a comprehensive quarterly financial report. The document length is 6346 characters, which is sufficient to contain detailed financial data rather than just an announcement. The term 'Quarterly Report (4C Statement)' is consistent with Australian Securities Exchange (ASX) quarterly reporting requirements. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2013
2013-04-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.